Development of Rapid Response Plan for Radiation Oncology in Response to Cyberattack

Affiliations

Carl J Nelson et al. Adv Radiat Oncol. 2020.

. 2020 Nov 19;6(1):100613.

doi: 10.1016/j.adro.2020.11.001. eCollection 2021 Jan-Feb.

¹ Division of Radiation Oncology, University of Vermont Larner College of Medicine, Burlington, Vermont.

No abstract available

References

1. Shaikh T., Handorf E.A., Murphy C.T., Mehra R., Ridge J.A., Galloway T.J. The impact of radiation treatment time on survival in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2016;96:967–975. - PMC - PubMed
1. Raphael M.J., Ko G., Booth C.M. Factors associated with chemoradiation therapy interruption and noncompletion among patients with squamous cell anal carcinoma. JAMA Oncol. 2020;6:881–887. - PMC - PubMed
1. Fyles A., Keane T.J., Barton M., Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25:273–279. - PubMed
1. Fortin A., Bairati I., Albert M., Moore L., Allard J., Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:929–936. - PubMed
1. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–146. - PubMed